Surunkali buyrak kasalligi bo‘lgan bolalarda jismoniy rivojlanishning buzilishi: immun disfunksiya va surunkali yallig‘lanishning roli

Qabul qilingan: 2026-05-28

Nashr etilgan: 2026-11-18

Annotatsiya

Bolalarda surunkali buyrak kasalligi (SBK) faol o‘sish davrida rivojlanadi va immun tizimi faoliyatining buzilishi bilan kechadi. Sharhda 1997–2026-yillarda chop etilgan 30 ta manba asosida SBKda jismoniy rivojlanish buzilishlarining mexanizmlari, ularni baholash va davolash usullariga oid ma’lumotlar umumlashtirildi. Dializ olayotgan bolalarning taxminan 30 foizida past bo‘ylilik kuzatiladi. Yaqqol past bo‘ylilik (dializ boshlanganda bolaning bo‘yi 1-persentildan past bo‘lishi) o‘lim xavfining qariyb ikki baravar yuqori bo‘lishi bilan bog‘liq. Jismoniy rivojlanish buzilishining asosiy mexanizmlariga oqsil-energetik yetishmovchilik, atsidoz, mineral almashinuvi va suyak to‘qimasidagi buzilishlar, anemiya hamda o‘sish gormoniga rezistentlik kiradi. Dializ olayotgan bolalarda T-limfotsitlar soni kamaygan bo‘ladi. Interleykin-6 va C-reaktiv oqsil darajalari bilan o‘sish ko‘rsatkichlari o‘rtasida teskari bog‘liqlik kuzatiladi. Bir tadqiqotda gepatit B ga qarshi emlashdan so‘ng dializni hali boshlamagan bolalarning 100 foizida, dializ olayotgan bemorlarning 94 foizida va buyrak transplantatsiyasidan o‘tgan bemorlarning 64 foizida antitanalar himoya darajasiga yetgani qayd etilgan. Davolash va profilaktika choralari ovqatlanishni qo‘llab-quvvatlash, metabolik buzilishlarni tuzatish, infeksiyalarning oldini olish, erta emlash, o‘sish gormoni bilan davolash hamda glukokortikoidlar qo‘llanishini imkon qadar kamaytirgan holda buyrak transplantatsiyasini o‘tkazishni o‘z ichiga oladi. O‘zbekistonda bu boradagi ma’lumotlar cheklangani SBK bilan kasallangan bolalarning jismoniy rivojlanishi va immun holatini mahalliy tadqiqotlarda o‘rganish zarurligini ko‘rsatadi.

Adabiyotlar ro'yxati

  1. Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol. 2012;27(3):363–73. https://doi.org/10.1007/s00467-011-1939-1

  2. Haffner D. Strategies for Optimizing Growth in Children With Chronic Kidney Disease. Front Pediatr. 2020;8:399. https://doi.org/10.3389/fped.2020.00399

  3. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3(5):1526–33. https://doi.org/10.221 5/CJN.00950208

  4. De Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, Poli V, et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest. 1997;99(4):643–50. https://doi.org/10.1172/JCI119207

  5. Furth SL, Stablein D, Fine RN, Powe NR, Fivush BA. Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics. 2002;109(5):909–13. https://doi.org/10.1542/peds.109.5.909

  6. Rodig NM, McDermott KC, Schneider MF, Hotchkiss HM, Yadin O, Seikaly MG, et al. Growth in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children Study. Pediatr Nephrol. 2014;29(10):1987–95. https://doi.org/10.1007/s00467-014-2812-9

  7. van Huis M, Bonthuis M, Sahpazova E, Mencarelli F, Spasojević B, Reusz G, et al. Considerable variations in growth hormone policy and prescription in paediatric end-stage renal disease across European countries-a report from the ESPN/ERA-EDTA registry. Nephrol Dial Transplant. 2016;31(4):609–19. https://doi.org/10.1093/ndt/gfv105

  8. Liang Y, Shen Y, Jiang Y. The burden of protein-energy wasting in children with CKD3-5D: an observational study. Front Pediatr. 2026;14:1671377. https://doi.org/10.3389/fped.2026.1671377

  9. Harambat J, Bonthuis M, van Stralen KJ, Ariceta G, Battelino N, Bjerre A, et al. Adult height in patients with advanced CKD requiring renal replacement therapy during childhood. Clin J Am Soc Nephrol. 2014;9(1):92–9. https://doi.org/10.2215/CJN.00890113

  10. Настаушева Н.С., Стахурлова Л.И., Жданова О.А., и др. Физическое развитие детей с хронической болезнью почек (ХБП). Нефрология. 2015;19(3):32–38. [Nastausheva NS, Stakhurlova LI, Zhdanova OA, et al. Fizicheskoe razvitie detei s khronicheskoi bolezn’yu pochek (KhBP). Nefrologiya. 2015;19(3):32–38. (in Russ)]

  11. Semash K, Akhmedov A, Dzhanbekov T, Umarov Q, Dustmurodov J. Implementation of a pediatric kidney transplantation program in Uzbekistan: Feasibility and early outcomes. World J Transplant. 2025;15(4):107728. https://doi.org/10.5500/wjt.v15.i4.107728

  12. Zavyalova AN, Lebedev DA, Novikova VP, Smirnova NN, Firsova LA. Komponentnyi sostav tela detei s khronicheskoi bolezn’yu pochek po rezul’tatam bioimpedansometrii. Acta Biomedica Scientifica. 2023;8(2):184–194. https://doi.org/10.29413/ABS.2023-8.2.18. (in Russ)

  13. Mahesh S, Kaskel F. Growth hormone axis in chronic kidney disease. Pediatr Nephrol. 2008;23(1):41–8. https://doi.org/10.1007/s00467-007-0527-x

  14. Akchurin O, Molino AR, Schneider MF, Atkinson MA, Warady BA, Furth SL. Longitudinal Relationship Between Anemia and Statural Growth Impairment in Children and Adolescents With Nonglomerular CKD: Findings From the Chronic Kidney Disease in Children (CKiD) Study. Am J Kidney Dis. 2023;81(4):457–465.e1. https://doi.org/10.1053/j.ajkd.2022.09.019

  15. Greenbaum LA, Muñoz A, Schneider MF, Kaskel FJ, Askenazi DJ, Jenkins R, et al. The association between abnormal birth history and growth in children with CKD. Clin J Am Soc Nephrol. 2011;6(1):14–21. https://doi.org/10.2215/CJN.08481109

  16. Drube J, Wan M, Bonthuis M, Wühl E, Bacchetta J, Santos F, et al. Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol. 2019;15(9):577–589. https://doi.org/10.1038/s41581-019-0161-4

  17. Neuhaus TJ. Immunization in children with chronic renal failure: a practical approach. Pediatr Nephrol. 2004;19(12):1334–9. https://doi.org/10.1007/s00467-004-1597-7

  18. Szczepańska M, Szprynger K, Mazur B, Szczepański T. Alphabeta and gammadelta T cell subsets in chronic renal failure in children on dialysis treatment. Pediatr Int. 2002;44(1):32–6. https://doi.org/10.104 6/j.1442-200x.2002.01501.x

  19. Sánchez Hernández KV, Larrosa-Haro A, González Hita M, Martín Del Campo López F, Chávez Palencia C, Pérez Cortez G, et al. Interleukine 6 and C-reactive protein predict growth impairment and acute malnutrition in children and adolescents with chronic kidney disease. Nutr Hosp. 2019;36(6):1248–53. https://doi.org/10.20960/nh.02640

  20. Chavers BM, Solid CA, Gilbertson DT, Collins AJ. Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States. J Am Soc Nephrol. 2007;18(3):952–9. https://doi.org/10.1681/ASN.2006040406

  21. Ng DK, Molino AR, Zhang S, Stonebrook EJ, Wong CS, Gyawali P, et al. The epidemiology of kidney and urinary tract infections in pediatric chronic kidney disease: prevalence, risk factors and association with GFR decline in the Chronic Kidney Disease in Children Study. Pediatr Nephrol. 2026;41(10):3377–87. https://doi.org/10.1007/s00467-026-07253-2

  22. Watkins SL, Alexander SR, Brewer ED, Hesley TM, West DJ, Chan IS, et al. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure. Am J Kidney Dis. 2002;40(2):365–72. https://doi.org/10.1053/ajkd.2002.34521

  23. Mericq V, Salas P, Pinto V, Cano F, Reyes L, Brown K, et al. Steroid withdrawal in pediatric kidney transplant allows better growth, lipids and body composition: a randomized controlled trial. Horm Res Paediatr. 2013;79(2):88–96. https://doi.org/10.1159/000347024

  24. Hogan J, Schneider MF, Pai R, Denburg MR, Kogon A, Brooks ER, et al. Grip strength in children with chronic kidney disease. Pediatr Nephrol. 2020;35(5):891–899. https://doi.org/10.1007/s00467-019-04461-x

  25. WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr Suppl. 2006;450:76–85. https://doi.org/10.1111/j.1651-2227.2006.tb02378.x

  26. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85(9):660–7. https://doi.org/10.2471/blt.07.043497

  27. KDOQI Work Group. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis. 2009;53(3 Suppl 2):S11–104. https://doi.org/10.1053/j.ajkd. 2008.11.017

  28. Karri MS, Dawman L, Sadasivam D, Vallabhaneni P, Mahajan S, Singh T, et al. Bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for body composition assessment in children with chronic kidney disease. Eur J Pediatr. 2026;185(9):679. https://doi.org/10.1007/s00431-026-07355-x

  29. Hodson EM, Willis NS, Craig JC. Growth hormone for children with chronic kidney disease. Cochrane Database Syst Rev. 2012;2012(2):CD003264. https://doi.org/10.1002/14651858.CD003264.pub3

  30. Al-Uzri A, Matheson M, Gipson DS, Mendley SR, Hooper SR, Yadin O, et al. The impact of short stature on health-related quality of life in children with chronic kidney disease. J Pediatr. 2013;163(3):736–41.e1. https://doi.org/10.1016/j.jpeds.2013.03.016

Mualliflar haqida

Nigora R.Safarova
Tashkent State Medical University
Dilfuza T.Ashurova
Tashkent State Medical University

Litsenziya

Qanday iqtibos keltirish kerak

1.
Surunkali buyrak kasalligi bo‘lgan bolalarda jismoniy rivojlanishning buzilishi: immun disfunksiya va surunkali yallig‘lanishning roli. MSU [Internet]. 2026 Nov. 18 [cited 2026 Nov. 18];5(4):18-26. Available from: https://fdoctors.uz/index.php/journal/article/view/291

O'xshash maqolalar

Siz ham ushbu maqola uchun {$ advancedSearchLink} olishingiz mumkin.


ISSN 2181-3612 (Online)